Predictive markers are identified through rigorous research and clinical trials. The process typically involves:
1. Discovery Phase: Researchers use techniques like genomics, proteomics, and bioinformatics to identify potential markers. 2. Validation Phase: The identified markers are validated through laboratory experiments and small-scale studies. 3. Clinical Trials: Large-scale clinical trials are conducted to confirm the efficacy and reliability of the markers in predicting treatment responses.
